Awardee OrganizationMEDICAL UNIVERSITY OF SOUTH CAROLINA
Description
Abstract Text
DESCRIPTION (provided by applicant): The abuse of the amphetamine-like
psychostimulants is a medical and social problem throughout the world. The
rewarding properties of these drugs are linked to their capacity to increase
extracellular concentration of dopamine in the forebrain, notably in the
nucleus accumbens. The dopaminergic neurons that innervate nucleus accumbens
originate in the ventral tegmental area which has been shown to play a critical
role in development of chronic drug effects. Despite the advances in our
understanding of cellular and molecular actions of these drugs, effective
pharmacological treatments for amphetamine and cocaine addiction remain
elusive. More recently, a number of investigations have shown that in addition
to dopaminergic role in psychostimulant effects, excitatory neurotransmission
also plays a very critical role. Glutamate is the major excitatory
neurotransmitter in the brain and both nucleus accumbens and ventral tegmental
area receive a major glutamatergic innervation from prefrontal cortex. These
studies suggest that drugs acting on excitatory neurotransmission may be
effective therapeutic agents for treating psychostimulant abuse. The data
presented in this proposal suggest that the recently discovered proteins that
bind to glutamate receptors can alter glutamatergic transmission and may play
an important role in long lasting neuroadaptations after repeated drug
exposure. The Homer family of proteins is one of the glutamate receptor binding
proteins that bind specifically to metabotropic glutamate receptors. The
expression of these proteins in nucleus accumbens is altered after repeated
cocaine exposure. Moreover, reducing the level of these proteins in NA during
repeated exposure to cocaine prevents the development of behavioral
sensitization. Based on these results and others in literature a series of
experiments are proposed to study the functional role of these scaffolding
proteins in excitatory transmission in nucleus accumbens and their role in drug
induced synaptic plasticity.
No Sub Projects information available for 1R01DA014328-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01DA014328-01A1
Patents
No Patents information available for 1R01DA014328-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01DA014328-01A1
Clinical Studies
No Clinical Studies information available for 1R01DA014328-01A1
News and More
Related News Releases
No news release information available for 1R01DA014328-01A1
History
No Historical information available for 1R01DA014328-01A1
Similar Projects
No Similar Projects information available for 1R01DA014328-01A1